Ipca Laboratories has announced the commencement of commercial production at its newly established green field manufacturing facility. Located at Village Hingani, District – Wardha, the plant is dedicated to producing Drug Intermediates and Active Pharmaceuticals Ingredients (APIs). The project represents a significant capital investment for the company, amounting to approximately Rs. 182 crores, and marks an expansion of its manufacturing capabilities as of February 9, 2026.
Commencement of Commercial Operations
Ipca Laboratories Limited is pleased to inform stakeholders that its new green field manufacturing facility has officially commenced commercial production. This strategic expansion is focused on the production of Drug Intermediates and Active Pharmaceuticals Ingredients (APIs).
Key Investment Details
The establishment of this facility represents a substantial commitment to enhancing production capacity. The total capital outlay for the project is reported to be approximately Rs. 182 crores. The physical location of this new site is Village Hingani, in the District of Wardha.
The announcement, dated February 9, 2026, confirms that the plant is now operational and ready to contribute to the company’s API and Intermediates supply chain.
Source: BSE
